Project Grant R01DK149274
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded Johns Hopkins University a Project Grant of $819,091 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research titled "Glucose Patterns and Clinical Outcomes in the Dallas Heart Study: A Pathway to Precision Diabetes." The grant extends through June 30, 2030, and funds a comprehensive investigation using...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative addresses critical health disparities in diabetes management by developing and testing adaptive intervention sequences designed to improve outcomes for individuals with...
- Federal Project Grant Award Summary Dr. San Diego at Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through July 31, 2030. The award supports a career development initiative (K01) that integrates continuous glucose monitoring (CGM) technology into diabetes self-management education and...
- Federal Project Grant Award Summary Integrated Medical Sensors Inc. received a $569,998 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025 through July 31, 2026. The award funds the development and validation of optimized data processing algorithms for real-time glucose monitoring on the company's proprietary multi-sensor...
- Summary of Federal Project Grant Award The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of September 12, 2025, and completion date of July 31, 2030. The grant funds the Michigan Diabetes Project, a research initiative designed to develop and evaluate a virtually administered,...
- Federal Grant Award Summary Scripps Health received a $574,932 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2026 through June 30, 2031. The award funds development and evaluation of the EDGE (Enhancing DULCE Digital with CGM-Driven Personalization, Peer Support, Gamification, and Engagement) intervention, a digital health platform...
- Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $799,752 to The Research Foundation for the State University of New York (effective July 1, 2026, through June 30, 2031) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a clinical research study comparing the efficacy of continuous glucose monitoring (CGM) relative to traditional finger-stick self-monitoring of...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $780,220 Project Grant on February 27, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and optimize a scalable digital behavioral intervention for reducing Level 2 hypoglycemia in adults with Type 1 Diabetes (T1D). The project, which will conclude by January 31, 2030,...
- Federal Project Grant Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $160,575 to the University of Illinois (awarded July 1, 2026, with completion by March 31, 2029) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct dissemination and implementation research examining how Federally Qualified Health Centers (FQHCs) adopt Medicaid Alternative Payment Models (APMs) and evidence-based practices in...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $784,276 Project Grant to the University of Houston System on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the "Supporting Monitoring and Remote Tracking for Prediabetes (SMART Prediabetes)" initiative, a five-year research project extending through June 30, 2031. The project delivers a comprehensive evaluation of continuous glucose monitor (CGM) use and implementation support for underinsured prediabetic populations served by Federally Qualified Health Centers (FQHCs) in Houston, Texas. The research initiative generates evidence-based products and services focused on addressing barriers to CGM adoption and utilization among safety-net populations. Deliverables include: (1) clinical research data comparing the impact of CGM use on glycemic awareness, behavioral modification, and HbA1c changes relative to standard care, stratified by pharmacologic therapy type; (2) targeted training and implementation guidance for community health workers at FQHCs to effectively support patient CGM use; and (3) multi-level barrier and facilitator analysis grounded in the Consolidated Framework for Implementation Research (CFIR) and the Capability, Opportunity, Motivation-Behavior (COM-B) model. These evidence-based outputs are designed to inform practice integration of technology-enabled remote monitoring into prediabetes management while reducing health equity gaps among vulnerable populations.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $784.3k | 7/1/26 |